[Equivalence studies in cardiovascular diseases].

Area of Science:

• Cardiovascular Medicine
• Clinical Trial Design
• Biostatistics

Background:

• Randomized clinical trials evaluating treatment efficacy increasingly utilize equivalence and non-inferiority designs.
• These study designs present unique methodological and ethical considerations.
• Cardiovascular medicine is a prominent field employing these trial types.

Purpose of the Study:

• To review and highlight critical methodological problems in equivalence and non-inferiority trials.
• To focus on specific challenges including equivalence boundary setting, logical frameworks for equivalence, and sample size determination.
• To identify key issues in study design and result interpretation for cardiovascular non-inferiority and equivalence trials.

Main Methods:

• A comprehensive literature search was conducted using Medline.
• The search focused on identifying publications discussing equivalence and non-inferiority trials in cardiovascular diseases.
• Key methodological aspects such as design and interpretation were analyzed.

Main Results:

• Equivalence and non-inferiority trials in cardiovascular medicine face significant methodological hurdles.
• Challenges include the appropriate definition of equivalence margins.
• Determining adequate sample sizes and applying correct statistical logic for equivalence are critical.

Conclusions:

• Methodological rigor is essential for the valid design and interpretation of cardiovascular equivalence and non-inferiority trials.
• Addressing issues in boundary setting, statistical logic, and sample size is paramount.
• Careful consideration of these factors ensures the reliable evaluation of treatment efficacy.